COVID-19 vaccine-induced Stevens-Johnson syndrome

S Dash; C S Sirka; S Mishra; P Viswan

doi:10.1111/ced.14784

COVID-19 vaccine-induced Stevens-Johnson syndrome

Clin Exp Dermatol. 2021 Dec;46(8):1615-1617. doi: 10.1111/ced.14784. Epub 2021 Aug 19.

Authors

S Dash¹, C S Sirka¹, S Mishra¹, P Viswan¹

Affiliation

¹ Department of Dermatology and Venereology, All India Institute of Medical Sciences (AIIMS), Bhubaneswar, India.

Abstract

Herein, we are reporting a case of Stevens–Johnson syndrome due to COVID‐19 vaccine, which has been proved by history taking, clinical examination and histopathology. To the best of our knowledge we are reporting the first case of COVID‐19 vaccine‐induced Stevens–Johnson syndrome.

Publication types

Case Reports
Letter

MeSH terms

Administration, Oral
COVID-19 / diagnosis
COVID-19 / epidemiology
COVID-19 / prevention & control*
COVID-19 / virology
Cyclosporine / administration & dosage
Cyclosporine / therapeutic use
Drug-Related Side Effects and Adverse Reactions / pathology
Humans
Immunosuppressive Agents / administration & dosage
Immunosuppressive Agents / therapeutic use
Male
Middle Aged
SARS-CoV-2 / genetics
SARS-CoV-2 / immunology
Skin / pathology
Stevens-Johnson Syndrome / diagnosis
Stevens-Johnson Syndrome / etiology*
Treatment Outcome

Substances

Immunosuppressive Agents
Cyclosporine